Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EPB41L2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PMS2CL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DEFB4B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLIP4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SSR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ERV9-1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors
HFE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPS14 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR21 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MXI1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CSHL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
THOC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HSPE1-MOB4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IGF2BP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
XPO7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARFIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IGK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TGFBR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZFY - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on